The Glu/Asp polymorphism of ecNOS gene and the renal progression in Korean autosomal dominant polycystic kidney disease (ADPKD) patients

Korean Journal of Genetics

Volumn 24, Issue 3, 2002, Pages 241-246

  Lee, Jung Geon ^a   Ahn, Curie ^b   Yoon, Sung Chul ^c   Park, Jong Hoon ^d   No, Jin Ju ^b   Moon, Chang Suk ^b   Song, Eun Kyeung ^b   Hwang, Yeong Hwan ^b   Hwang, Dae Yeon ^b   Kim, Yon Su ^b   Han, Jin Suk ^b   Kim, Suhnggwon ^b   Lee, Jung Sang ^b   Kim, Seung Hyup ^b  

^a Eulji University School of Medicine   (South Korea)

^b Seoul National University   (South Korea)

^c Dankook University   (South Korea)

^d Sookmyung Women's University   (South Korea)

Author keywords

Autosomal dominant polycystic kidney disease (ADPKD); ecNOS; Glu298Asp polymorphism; Korean

Indexed keywords

ASPARTIC ACID; GLUTAMIC ACID;

ADULT; ALLELE; AMINO ACID SUBSTITUTION; ARTICLE; AUTOSOMAL DOMINANT DISORDER; BLOOD PRESSURE; CHRONIC DISEASE; CHRONIC KIDNEY FAILURE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; DNA POLYMORPHISM; FEMALE; GENE; GENE IDENTIFICATION; GENE LOCUS; GENETIC ASSOCIATION; GENOTYPE; HUMAN; HYPERTENSION; INTERSTITIAL NEPHRITIS; KIDNEY; KIDNEY POLYCYSTIC DISEASE; KOREA; MAJOR CLINICAL STUDY; MALE; PATIENT; POLYMERASE CHAIN REACTION; POPULATION; PROTEIN POLYMORPHISM; PROTEIN VARIANT; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; VASCULAR DISEASE;

EID: 18644373441     PISSN: 02545934     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Baboolal K, Ravine D, Daniels J, Williams N, Holmans P, Coles GA and Williams JD (1997) Association of the angiotensin I converting enzyme gene deletion polymorphism with early onset of ESRF in PKD1 adult polycystic kidney disease. Kidney Int 52: 607-613.
2. Choe SY, Yu KH, Park JS, Chae IH, Kim HS, Son DW and Oh BH (2000) eNOS gene polymorphism in patients with acute coronary syndrome or variant angina in Korea. Korean J Intern Med 58: 19-27.
3. Elbaz A, Poirier O, Moulin T, Chedru F, Cambien F and Amarenco P (2000) Association between the Glu298Asp polymorphism in the endothelial constitutive nitric oxide synthase gene and brain infarction. The GENIC Investigators. Stroke 31: 1634-1639.
4. Grantham JJ (1996) The etiology, pathogenesis, and treatment of autosomal dominant polycystic kidney disease: recent advances. Am J Kidney Dis 28: 788-803.
5. Grantham JJ (1997) Mechanisms of progression in autosomal dominant polycystic kidney disease. Kidney Int 52(suppl 63): S93-S97.
6. Gustincich S, Manfioletl G, Del Sal G, Schneider C and Carninci P (1991) A fast method for high-quality genomic DNA extraction from whole human blood. Bio Techniques 11: 298-302.
7. Hateboer N, Dijk MA, Bogdanova N, Coto E, Saggar-Malik AK, San Millan JL, Torra R, Breuning M and Ravine D (1999a) Comparison of phenotypes of PKD types 1 and 2. Lancet 353: 103-107.
8. Hateboer N, Lazarou LP, Williams AJ, Holmans P and Ravine D (1999b) Familial phenotype differences in PKD1. Kidney Int 56: 34-40.
9. Jeong HG, Gu HK and Jeong TC (1997) Genetic polymorphism cytochrome P450 1A1 in Korean population. Korean J. Genetics 19: 109-117.
10. Kim UK, Jin DK, Ahn C, Shin JH, Lee KB, Kim SH, Chae JJ, Hwang DY, Lee JG, Namkoong Y and Lee CC (2000) Novel mutations of the PKD1 gene in Korean patients with autosomal dominant polycystic kidney disease. Mutat Res 432: 39-45.
11. Kimberling WJ, Fain PR, Kenyon JB, Goldgar D, Sujansky E and Gabow P (1988) Linkage heterogeneity of autosomal dominant polycystic kidney disease. N Engl J Med 319: 913-918.
12. Ko HE, Nakayama T, Tokunaga K, Park KS (2000) Polymorphisms of the TNFA promotor region among Koreans. Korean J. Genetics 22: 275-280.
13. Korean Society of Nephrology, Registry Committee (1999) Renal replacement therapy in Korea. Korean J Nephrol 18(supp4): S343-S367.
14. Lacolley P, Gautier S, Poirier O, Pannier B, Cambien F and Benetos A (1998) Nitric oxide synthase gene polymorphisms, blood pressure and aortic stiffness in normotensive and hypertensive subjects. J Hypertens 16: 31-35.
15. Lee JG, Lee KB, Kim UK, Ahn C, Hwang DY, Hwang YH, Eo H-S, Lee EJ, Kim YS, Han JS, Kim S and Lee JS (2001) Genetic heterogeneity in Korean families with ADPKD: the first Asian report. Clin Genet 60: 138-144.
16. Lembo G, De Luca N, Battagli C, Iovino G, Aretini A, Musicco M, Frati G, Pompeo F, Vecchione C and Trimarco B (2001) A common variant of endothelial nitric oxide synthase(Glu298Asp) is an independent risk factor for carotid atherosclerosis. Stroke 32: 735-740.
17. Lieske JC and Toback FG (1993) Autosomal dominant polycystic kidney disease. J Am Soc Nephrol 3: 1442-1450.
18. MacLeod MJ, Dahiyat MT, Cumming A, Meiklejohn D, Shaw D and St Clair D (1999) No association between Glu/Asp polymorphism of NOS3 gene and ischemic stroke. Neurology 53: 418-420.
19. Marsden PA, Heng HH, Scherer SW, Stewart RJ, Hall AV, Shi XM, Tsui LC and Schappert KT (1993) Structure and chromosomal localization of the human constitutive endothelial nitric oxide synthase gene. J Biol Chem 268: 17478-17488.
20. Milutinovic J, Rust PF, Fialkow PJ, Agodoa LY, Phillips LA, Rudd TG and Sutherland S (1992) Intrafamilial phenotypic expression of autosomal dominant polycystic kidney disease. Am J Kidney Dis 19(5): 465-472.
21. Murcia NS, Sweeney WE and Avner ED (1999) New insights into the molecular pathophysiology of polycystic kidney disease. Kidney Int 55: 1187-1197.
22. Parfrey PS, Bear JC, Morgan J, Cramer BC, McManamon PJ, Gault MH, Churchill DN, Singh M, Hewitt R and Somlo S (1990) The diagnosis and prognosis of autosomal dominant polycystic kidney disease. N Engl J Med 323: 1085-1090.
23. Peters DJ, Spruit L, Saris JJ, Ravine D, Sandkuijl LA, Fossdal R, Boersma J, van Eijk R, Norby S and Constantinou-Deltas CD (1993) Chromosome 4 localization of a second gene for autosomal dominant polycystic kidney disease. Nat Genet 5(4): 359-352.
24. Raij L and Baylis C (1995) Glomerular actions of nitric oxide. Kidney Int 48: 20-32.
25. Raij L (1998) Nitric oxide in hypertension: relationship with renal injury and left ventricular hypertrophy. Hypertension 31: 189-193.
26. Shimasaki Y, Yasue H, Yoshimura M, Nakayama M, Kugiyama K, Ogawa H, Harada E, Masuda T, Koyama W, Saito Y, Miyamoto Y, Ogawa Y and Nakao K (1998) Association of the missense Glu298Asp variant of the endothelial nitric oxide synthase gene with myocardial infarction. J Am Coll Cardiol 31: 1506-1510.
27. Shoji M, Tsutaya S, Saito R, Takamatu H and Yasujima M (2000) Positive association of endothelial nitric oxide synthase gene polymorphism with hypertension in northern Japan. Life Sci 66: 2557-2562.
28. Tanus-Santos JE, Desai M and Flockhart DA (2001) Effects of ethnicity on the distribution of clinically relevant endothelial nitric oxide variants. Pharmacogenetics 11: 719-725.
29. Torra R, Badenas C, Darnell A, Nicolau C, Voipini V, Revert L and Estivil X (1996) Linkage, clinical features, and prognosis of ADPKD types 1 and 2. J Am Soc Nephrol 7: 2142-2151.
30. Ukkola O, Erkkila PH, Savolainen MJ and Kesaniemi YA (2001) Lack of association between polymorphisms of catalase, copper-zinc superoxide dismutase, extracellular SOP and endothelial nitric oxide synthase genes and macroangiopathy in patients with type 2 diabetes mellitus. J Intern Med 249: 451-459.
31. van Dijk MA, Breuning MH, Peters DJM and Chang PC (2000) The ACE insertion/deletion polymorphism has no influence on progression of renal function loss in autosomal dominant polycystic kidney disease. Nephrol Dial Transplant 15: 836-839.
32. Yoshimura M, Yasue H, Nakayama M, Shimasaki Y, Ogawa H, Kugiyama K, Saito Y, Miyamoto Y, Ogawa Y, Kaneshige T, Hiramatsu H, Yoshioka T, Kamitani S, Teraoka H and Nakao K (2000) Genetic risk factors for coronary artery spasm: significance of endothelial nitric oxide synthase gene T-786→C and missense Glu298Asp variants. J Investig Med 48: 367-374.
33. Yoshimura T, Yoshimura M, Tabata A, Yasue H and Okamura H (2001) The missense Glu298Asp variant of the endothelial nitric oxide synthase gene is strongly associated with placental abruption. Hum Genet 108: 181-183.